Persistence of hepatic hepatitis B virus after serological clearance of HBsAG with autologous peripheral stem cell transplantation

Journal of Clinical Pathology

Volumn 50, Issue 8, 1997, Pages 706-708

  Lau, George K K ^a   Wu, Pui Chee ^a   Liang, Raymond ^a   Yuen, Siu Tsan ^a   Lim, Wei Ling ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Hepatitis B virus; High dose chemotherapy; Lymphoma; Peripheral blood stem cell; Virus persistence

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; HEPATITIS B SURFACE ANTIGEN; IFOSFAMIDE; METHOTREXATE; PREDNISONE; VINCRISTINE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CASE REPORT; HEPATITIS B; HEPATITIS B VIRUS; HOST SUSCEPTIBILITY; HUMAN; INFECTION RISK; LIVER BIOPSY; MALE; NONHODGKIN LYMPHOMA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SERODIAGNOSIS; VIRUS DETECTION; VIRUS REACTIVATION;

EID: 9844256435     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.50.8.706     Document Type: Article

References (11)

1. Lok ASF. Natural history and control of perinatally acquired hepatitis B virus infection. Dig Dis 1992;10:46-52.
2. Vincenzo B, Balsano F. Immunologic and molecular basis of viral persistence. The hepatitis B virus model. J Hepatol 1992;14:391-400.
3. Lau GKK, Liang R, Chiu EKW, Lee CK, Lam SK. Loss of HBsAg in chronic hepatitis B carrier following high dose chemotherapy and autologous peripheral blood stem cell rescue for lymphoma [letter]. Am J Hematol 1995;50:317-18.
4. Rehermann B, Ferrari C, Pasquinelli C, Chisari FV. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nature Med 1996;2: 1104-8.
5. Lau GKK, Lok ASF, Liang R, Lai CL, Chiu EKW, Lau YL, et al. Clearance of chronic hepatitis B infection after bone marrow transplantation: role of adoptive immunity transfer. Hepatology 1997;25:1497-501.
6. Shindo M, Okuno T, Arai K, Matsumoto M, Takeda M, Kashima K, et al. Detection of hepatitis B virus DNA in paraffin-embedded liver tissue in chronic hepatitis B or non-A,non-B hepatitis using the polymerase chain reaction. Hepatology 1991;13:167-71.
7. Knodell RG, Ishak KG, Black WC, Chen T, Crag R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1:431-5.
8. Wu PC, Fang WS, Lai CL, Lau SK, Lo CK, Lai A, et al. Hepatic expression of hepatitis B virus genome in chronic hepatitis B virus infection. Am J Clin Pathol 1996;105:87-95.
9. Fong TL, Di Bisceglie AM, Gerber MA, Waggoner JG, Hoofnagle JH. Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B. Hepatology 1993;18:1313-18.
10. Lok ASF, Liang RHS, Chiu EKW, Wong KL, Chan TK, Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Gastroenterology 1991; 100:182-8.
11. Hoofnagle JH, Seeff LB, Bales ZB, Zimmerman HJ. Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N Engl J Med 1978;298:1379-83.